



































An increasing number of people are turning to 
supplements of fish oil and of its omega-3 poly-
unsaturated fatty acids eicosapenatenoic acid (EPA) and 
docosahexaenoic acid (DHA). These fatty acids can 
only be synthesized in mammals from the dietary 
precursor and essential fatty acid, α-linolenic acid [1]. 
However, the synthesis pathway requires a number of 
elongation and desaturation steps, making direct uptake 
from the diet a more effective route of assimilation. The 
EPA and DHA in the human diet are derived indirectly 
from marine algae (higher plants lack the enzymes for 
the biosynthesis of these lipids) and their bioavailability 
is dramatically increased as they pass up the food chain 
and are concentrated in the flesh of marine fish. Sales of 
omega-3 supplements have been growing steadily and 








































and omega-3 products in general are worth many 
billions in sales every year. 
 
The growing public and clinical interest in fish oil and 
its omega-3 fatty acids is not surprising considering the 
large number of studies reporting health benefits of fish, 
fish oil and omega-3 fatty acids consumption. 
Triggering interest in fish oil were studies conducted in 
Greenland Eskimos showing that large amounts of fish 
consumption protected against heart disease, in spite of 
a large intake of fat and cholesterol [3–6]. Since then 
several epidemiologic studies have associated reduced 
risk of cardiovascular disease with fish or fish oil 
consumption [7–10]. Furthermore, one study in 
coronary heart patients found that blood levels of 
omega-3 fatty acids were inversely associated with telo- 

















Fish  oil  supplementation  is  of  great  medical  and  public  interest  with  epidemiological  evidence  of  health
benefits  in  humans,  in  particular  by  conferring  protection  against  heart  diseases.  Its  anti‐inflammatory




mice  in  three  sites,  part  of  the  Interventions  Testing  Program  of  the  NIA,  Strong  et  al.  show  that  fish  oil
supplementation at either low or high dosages has no effect on the lifespan of male or female mice. Although it
is still possible  that  fish oil supplementation has health benefits  for specific age‐related diseases,  it does not
appear to slow aging or have longevity benefits. 
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mere shortening [11]. Fish oil has been shown to impact 
on several risk factors associated with coronary heart 
disease [3]. Briefly, fish oil lowers triglyceride levels 
[9]. This has been observed in human studies in a dose-
response manner, accompanied by increases in LDL 
cholesterol (and to a lower degree HDL cholesterol) 
levels [12]. Both EPA and DHA, in fact, have 
triglyceride-lowering properties [13]. In patients with 
mild hypertension, but not in healthy subjects, 
consumption of omega-3 fatty acids has been shown to 
decrease systolic and diastolic blood pressures [14]. 
One hypothesis is that, by modulating inflammation 
within the artery wall, omega-3 fatty acids also alter the 
structural composition of advanced atherosclerotic 
plaques in a manner that could reduce the incidence of 
plaque rupture or ulceration, a process that precedes 
tissue infarction (e.g. heart attack or stroke) [15]. 
 
Although the benefits of fish oil have been more widely 
studied in the context of heart disease, studies suggest 
that consumption of fish oil or of its omega-3 fatty acids 
may have beneficial effects on stroke, depression, 
diabetes mellitus, cancer and Alzheimer’s disease 
[3,5,16,17]. Because dietary omega-3 polyunsaturated 
fatty acids have anti-inflammatory properties, their 
beneficial effects have been reported for pathologies 
and conditions associated with inflammation. For 
example, oral supplements containing omega-3 fatty 
acids reduced symptoms and clinical scores associated 
with inflammatory activity in psoriasis [18]. Similarly, 
fish oil consumption has been shown to reduce the 
symptoms of disease as well as the use of non-steroidal 
anti-inflammatory drugs in arthritis patients with severe 
inflammatory joint disease [19]. One study showed that 
fish oil supplementation induces anti-inflammatory 
gene expression profiles in human blood mononuclear 
cells [20]. In vitro studies have also suggested that 
omega-3 fatty acids have direct effects on inflammatory 
responses [21–23]. 
 
Numerous studies in mice have supported the beneficial 
roles of fish oil consumption. Succinctly, in mice, fish 
oil may have beneficial effects on arthritis [24], cancer 
[25], cardiac arrhythmias [26] and on bone mass during 
aging [27]. In murine models of atherosclerosis, the 
burden of arterial plaque was reduced upon omega-3 
fatty acid supplementation [28]. One study reported 
beneficial effects of dietary omega-3 polyunsaturated 
fatty acids on toxin-induced neuronal degeneration in an 
animal model of Parkinson's disease [29]. 
 
Fish oil has been shown to increase lifespan by over 
40% in autoimmune-prone (NZB x NZW)F(1) female 
mice [30–33]. Lifespan extension in this NZB/W strain 
was accompanied by decreased body weight and 
lowered inflammation levels such as lower NFkB. 
Interestingly, enhanced antioxidant enzyme (superoxide 
dismutase, catalase and glutathione peroxidase) 
activities were also observed and may partly explain the 
lower NFkB levels [30,31]. Moreover, a demographic 
analysis of these fish oil-fed NZB/W revealed that fish 
oil could shift the Gompertz slope, suggesting that fish 
oil may delay the rate of aging in NZB/W mice [34]. 
Another study in mice found evidence of increased 
antioxidant gene expressions in response to fish oil, 
though it is possible that this is a defense mechanism 
since fish oil is easily peroxidized [35]. As such, fish oil 
affects pathways thought to be involved in the regulation 
of aging, making it a candidate geroprotector. There is 
enormous interest in discovering and developing 
geroprotectors [36], and given that a significant number 
of people already self administer omega-3 fatty acids for 
health reasons, evaluating if fish oil is a geroprotector is 
of great scientific and public interest. 
 
For the above reasons, we proposed fish oil to the 
Interventions Testing Program (ITP) of the NIA, which 
investigates the effects of treatments or compounds on 
the lifespan and aging of mice. Our proposal was 
approved and two dosages were tested across three sites 
using a large cohort (n = 287 males and 267 females) of 
genetically heterogeneous mice. The results reveal no 
significant longevity benefits of fish oil 
supplementation of either dose on either sex [37]. A 
dose-dependent increase in body weight was observed 
in males at 18 months of age. There was some variation 
across the three sites with an 18% decline in male 
longevity observed for the higher dose in one site while 
a 9% increase in lifespan was observed for males at 
another site for the lower dosage [37]. Nonetheless, the 
pooled results do not reveal any significant effects of 
fish oil on mouse longevity. 
 
Other recent murine studies also raise questions about 
the health and longevity benefits of fish oil. One small 
(n =14) study previously found no lifespan effect of fish 
oil supplementation in female C57BL/6 mice [38]. 
Another study found fish oil supplementation to shorten 
mean lifespan in F1 mice by 4.7 to 9.8% [39]. Because 
NZB/W female mice are slightly obese, autoimmune-
prone, short-lived animals, the life extension caused by 
fish oil in NZB/W mice could be due to a delay of 
inflammation-triggered pathologies which are more 
severe in NZB/W mice. Indeed, one more recent study 
suggests that DHA in particular suppresses IL-18-
dependent signaling and glomerulonephritis in NZB/W 
mice [40]. However, one study found that dietary fish 
oil in a mouse model of inflammatory colitis induces 
severe colitis and adenocarcinoma formation [41]. In 
another short-lived mouse model, long-term dietary fish 
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oil decreased lifespan [42], again suggesting that fish 
oil’s longevity benefits are limited to very specific 
strains. Nevertheless, given the importance of 
inflammation in aging [43], it is surprising that fish oil 
had no longevity benefits as part of the ITP. 
 
A number of recent clinical trials also failed to 
substantiate the benefits of fish oil supplements. Of 18 
clinical trials and 6 meta-analysis of omega-3 
supplements, only 2 reported benefits [2]. Moreover, 
one recent study found that the indigenous people of 
Greenland have genetic and physiological adaptations to 
a diet rich in omega-3 [44]. One possibility is that the 
benefits of fish oil consumption depend on one's own 
individual genetic makeup, and some populations will 
have greater benefits than others. This is not unexpected 
given that we know that many longevity interventions 
depend on genome-environment interactions [45]. 
Although longevity benefits for fish oil supplements 
seem unlikely, it is still possible that fish oil 
supplements have a positive impact on specific age-
related diseases or conditions. One of the limitations of 
the ITP study was that no pathological analysis was 
performed on the animals. Nonetheless, because mice 
die primarily of cancer, geroprotectors that primarily 
influence cancer will be more readily detected in mice 
[46]. One largely unexplored area concerns changes in 
sensitivity to supplementation with age, in particular if 
disease is superimposed on the aged. It may be that fish 
oil supplements are beneficial at some ages and for 
some conditions but neutral or even detrimental at 
others. Further studies are necessary to gain clarity on 
its possibility. 
 
In conclusion, fish oil supplementation does not extend 
longevity in normal healthy mice. Although specific 
health benefits of fish oil cannot be excluded, omega-3 
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